Immune recognition of foreign DNA: A cure for bioterrorism?

Immunity

Volumn 11, Issue 2, 1999, Pages 123-129

  Klinman, Dennis M ^a   Verthelyi, Daniela ^a   Takeshita, Fumihiko ^a   Ishii, Ken J ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DNA VACCINE; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 12; OLIGODEOXYNUCLEOTIDE; PLASMID VECTOR;

BACTERIAL INFECTION; BIOLOGICAL WARFARE; HUMAN; IMMUNIZATION; IMMUNOGENICITY; IMMUNOMODULATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; VACCINATION; VIRUS INFECTION;

EID: 0033179892     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80087-4     Document Type: Review

References (92)

1. Altas, R.M. (1998). The medical threat of biological weapons. Crit. Rev. Microbiol. 24, 157-168.
2. Bachmaier, K., Meu, N., Maza, L.M., Pal, S., Nessel, A., and Penninger, J.M. (1999). Chlamydia infections and heart disease linked through antigenic mimicry. Science 283, 1335-1339.
3. Ballas, Z.D., Rasmussen, W.L., and Krieg, A.M. (1996). Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. J. Immunol. 157, 1840-1847.
4. Bird, A.P. (1987). CpG-rich islands and the function of DNA methylation. Trends Genet. 3, 342-347.
5. Boyer, J.D., Ugen, K.E., Wang, B., Agadjanyan, M., Gilbert, L., Bagarazzi, M.L., Chayyergoon, M., Frost, P., Javadian, A., Williams, W.V., et al. (1997). Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination. Nat. Med. 3, 526-532.
6. Branda, R.F., Moore, A.L., Lafayette, A.R., Mathews, L., Hong, R., Zon, G., Brown, T., and McCormack, J.J. (1996). Amplification of antibody production by phosphorothioate oligodeoxynucleotides. J. Lab. Clin. Med. 128, 329-338.
7. Brazolot Millan, C.L., Weeratna, R., Krieg, A.M., Siegrist, C.A., and Davis, H.L. (1998). CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice. Proc. Natl. Acad. Sci. USA 95, 15553-15558.
8. Calarota, S., Bratt, G., Nordlund, S., Hinkula, J., Leandersson, A.D., Sandstrom, E., and Wahren, B. (1998). Cellular cytotoxic response induced by DNA vaccination in HIV-1 infected patients. Lancet 351, 1320-1325.
9. Chu, R.S., Targoni, O.S., Krieg, A.M., Lehmann, P.V., and Harding, C.V. (1997). CpG oligodeoxynucleotides act as adjuvants that switch on T helper (Th1) immunity. J. Exp. Med. 186, 1623-1631.
10. Cohen, A.D., Boyer, J.B., and Weiner, D.B. (1998). Modulating the immune response to genetic immunization. FASEB J. 12, 1611-1625.
11. Cowdery, J.S., Chace, J.H., Yi, A., and Krieg, A.M. (1996). Bacterial DNA induces NK cells to produce IFNgamma in vivo and increases the toxicity of lipopolysaccharides. J. Immunol. 156, 4570-4575.
12. Davis, H.L. (1999). Use of CpG DNA for enhancing specific immune responses. Curr. Top. Microbiol. Immunol., in press.
13. Davis, H.L., and Brazolot Millan, C.L. (1997). DNA-based immunization against hepatitis B virus. Springer Semin. Immunopathol. 19, 195-209.
14. Davis, H.L., Weeranta, R., Waldschmidt, T.J., Tygrett, L., Schorr, J., and Krieg, A.M. (1998). CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J. Immunol. 160, 870-876.
15. Effros, R.B., and Walford, R.L. (1983). Diminished T cell response to influenza virus in aged mice. Immunology 49, 387-393.
16. Elkins, K.L., Rhinehart-Jones, T.R., Stibitz, S., Conover, J.S., and Klinman, D.M. (1999). Bacterial DNA protects mice against lethal infection by intracellular bacteria. J. Immunol. 162, 2991-2997.
17. Gilkeson, G.S., Riuz, P., Howell, D., Lefkowith, J.B., and Pisetsky, D.S. (1993). Induction of immune-mediated glomerulonephritis in normal mice immunized with bacterial DNA. Clin. Immunol. Immunopathol. 68, 283-292.
18. Gilkeson, G.S., Pippen, A.M., and Pisetsky, D.S. (1995). Induction of cross-reactive anti-dsDNA antibodies in preautoimmune NZB/NZW mice by immunization with bacterial DNA. J. Clin. Invest. 95, 1398-1402.
19. Gilkeson, G.S., Conover, J.S., Halpern, M., Pisetsky, D.S., Feagin, A., and Klinman, D.M. (1998). Effects of bacterial DNA on cytokine production by (NZB/NZW)F1 mice. J. Immunol. 161, 3890-3895.
20. Gu, M., Leppla, S.H., and Klinman, D.M. (1999). Protection against anthrax toxin by vaccination with a DNA plasmid encoding anthrax protective antigen. Vaccine 17, 340-344.
21. Hacker, H., Mischak, H., Miethke, T., Liptay, S., Schmid, R., SparwasSer, T., Heeg, K., Lipford, G.B., and Wagner, H. (1998). CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation. EMBO J. 17, 6230-6540.
22. Hadden, J.w. (1993). Immunomodulation. Immunol. Today 14, 275-280.
23. Halpern, M.D., Kurlander, R.J., and Pisetsky, D.S. (1996). Bacterial DNA induces murine interferon-gamma production by stimulation of IL-12 and tumor necrosis factor-alpha. Cell. Immunol. 167, 72-78.
24. Hartikka, J., Sawdey, M., Cornefert-Jensen, F., Margalith, M., Barnhart, K., Nolasco, M., Vahlsing, H.L., Meek, J., Marquet, M., Hobart, P., et al. (1996). An improved plasmid DNA expression vector for direct injection into skeletal muscle. Hum. Gene Ther. 7, 1205-1217.
25. Hartmann, G., Krug, A., Waller, K., and Endres, S. (1996). Oligodeoxynucleotides enhance LPS-stimulated synthesis of TNF:dependence on phosphorothioate modification and reversal by heparin. Mol. Med. 2, 429-438.
26. Henderson, D.A. (1999). The looming threat of bioterrorism. Science 283, 1279-1282.
27. Hengge, U.R., Chan, E.F., Foster, R.A., Walker, P.S., and Vogel, J.C. (1995). Cytokine gene expression in epidermis with biological effects following injection of naked DNA. Nat. Genet. 10, 161-166.
28. Horner, A.A., Ronaghy, A., Cheng, P.M., Nguyen, M.D., Cho, H.J., Broide, D., and Raz, E. (1998). Immunostimulatory DNA is a potent mucosal adjuvant. Cell Immunol. 190, 77-82.
29. Ishii, K.J., Weiss, W.R., Ichino, M., Verthelyi, D., and Klinman, D.M. (1999). Activity and safety of DNA plasmids encoding IL-4 and IFNgamma. Gene Ther. 6, 237-244.
30. Iwasaki, A., Stiernholm, B.J., Chan, A.K., Berinstein, N.L., and BarBer, B.H. (1997). Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines. J. Immunol. 158, 4591-4601.
31. Jakob, T., Walker, P.S., Krieg, A.M., Udey, M.C., and Vogel, J.C. (1998). Activation of cutaneous dendritic cells by CpG containing oligodeoxynucleotides: A role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA. J. Immunol. 161, 3042-3049.
32. Johnston, S.A., and Barry, M.A. (1997). Genetic to genomic vaccination. Vaccine 15, 808-809.
33. Katsumi, A., Emi, N., Abe, A., Hasegawa, Y., Ito, M., and Saito, H. (1994). Humoral and cellural immunity to an encoded protein induced by direct DNA injection. Hum. Gene Ther. 5, 1335-1339.
34. Kim, J.J., Trivedi, N.N., Nottingham, L.K., Morrison, L., Tsai, A., Hu, Y., Maharingam, S., Dang, K., Ahn, L., Doyle, N.K., et al. (1998). Modulation of amplitude and direction of in vivo immune responses by coadministration of cytokine gene expression cassettes with DNA immunogen. Eur. J. Immunol. 28, 1089-1103.
35. Klinman, D.M. (1998). Therapeutic applications of CpG-containing oligodeoxynucleotides. Antisense Nucleic Acid Drug Dev. 8, 181-184.
36. Klinman, D.M., Yi, A., Beaucage, S.L., Conover, J., and Krieg, A.M. (1996). CpG motifs expressed by bacterial DNA rapidly induce lymphocytes to secrete IL-6, IL-12, and IFNγ. Proc. Natl. Acad. Sci. USA 93, 2879-2883.
37. Klinman, D.M., Yamshchikov, G., and Ishigatsubo, Y. (1997). Contribution of CpG motifs to the immunogenicity of DNA vaccines. J. Immunol. 158, 3635-3642.
38. Klinman, D.M., Barnhart, K.M., and Conover, J. (1999). CpG motifs as immune adjuvants. Vaccine 17, 19-25.
39. Kovarik, J., Bozzotti, P., Love-Homan, L., Pihlgren, M., Davis, H.L., Lambert, P., Krieg, A.M., and Siegrist, C.A. (1999). CpG oligonucleotides can cirmcuvent the TH2 polorization of neonatal responses to vaccines but fail to fully redirect TH2 responses established by neonatal priming. J Immunol. 162, 1611-1617.
40. Krieg, A.M. (1995). CpG DNA: A pathogenic factor in systemic lupus erythematosus? J. Clin. Immunol. 15, 284-292.
41. Krieg, A.M., Yi, A., Matson, S., Waldschmidt, T.J., Bishop, G.A., Teasdale, R., Koretzky, G.A., and Klinman, D.M. (1995). CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374, 546-548.
42. Krieg, A.M., Homan, L.L., Yi, A.K., and Harty, J.T. (1998a). CpG DNA induces sustained IL-12 expression in vivo and resistance to Listeria monocytogenes challenge. J. Immunol. 161, 2428-2434.
43. Krieg, A.M., Wu, T., Weeratna, R., Efler, S.M., Love, L., Yang, L., Yi, A., Short, D., and Davis, H.L. (1998b). Sequence motifs in adenoviral DNA block immune activation by stimuatory CpG motifs. Proc. Natl. Acad. Sci. USA 95, 12631-12636.
44. Liang, H., Nishioka, Y., Reich, C.F., Pisetsky, D.S., Wagner, H., and Heeg, K. (1996). Activation of human B cells by phosphorothioate oligodeoxynucleotides. J. Clin. Invest. 98, 1119-1129.
45. Lipford, G.B., Bauer, M., Blank, C., Reiter, R., Wagner, H., and Heeg, K. (1997). CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: A new class of vaccine adjuvants. Eur. J. Immunol. 27, 2340-2344.
46. Liu, M.A., Fu, T.M., Donnelly, J.J., Caulfield, M.J., and Ulmer, J.B. (1998). DNA vaccines: Mechanisms for generation of immune responses. Adv. Exp. Med. Biol. 452, 187-191.
47. Manthorpe, M., Cornefert, J.F., Hartikka, J., Felgner, J., Rundell, A., Margalith, M., and Dwarki, V. (1993). Gene therapy by intramuscular injection of plasmid DNA: Studies on firefly luciferase gene expression in mice. Hum. Gene Ther. 4, 419-431.
48. Marrack, P., and Kappler, J. (1994). Submersion of the immune system by pathogens. Cell 76, 323-332.
49. Martin, T., Parker, S.E., Hedstrom, R., Le, T., Hoffman, S.L., Norman, J., Hobart, P., and Lew, D. (1999). Plasmid DNA malaria vaccine: The potential for genomic integration after intramuscular injection. Hum. Gene Ther. 10, 759-768.
50. McCluskie, M.J., and Davis, H.L. (1998). CpG DNA is a potent enhancer of systemic and mucosal immune responses against hepatitis B surface antigen with intranasal administration to mice. J. Immunol. 161, 4463-4466.
51. Medzhitov, R., and Janeway, C.A. (1997). Innate immunity: Impact on the adaptive immune response. Curr. Opin. Immunol. 9, 4-9.
52. Medzhitov, R., and Janeway, C.A. (1998). Innate immunity: The virtues of a nonclonal system of recognition. Cell 91, 295-298.
53. Moldoveanu, Z., Love-Homan, L., Huang, W.Q., and Krieg, A.M. (1998). CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus. Vaccine 16, 1216-1224.
54. Monteith, D.K., Henry, S., Howard, R.B., Flournoy, S., Levin, A., Bennett, C.F., and Crooke, S.T. (1997). Immune stimulation - a class effect of phophorothioate oligodeoxynucleotides in rodents. Anti-cancer Drug Des. 12, 421-432.
55. Monteith, D.K., Horner, M.J., Gillett, N.A., Butler, M., Geary, R., BurCkin, T., Ushiro, T., and Levin, A.A. (1999). Evaluation of the renal effects of an antisense phosphorothioate ODN in monkeys. Toxicol. Pathol. 27, 307-317.
56. Mor, G., Singla, M., Steinberg, A.D., Hoffman, S.L., Okuda, K., and Klinman, D.M. (1997). Do DNA vaccines induce autoimmune disease? Hum. Gene Ther. 8, 293-300.
57. Noll, A., Bucheler, N., Bonn, E., Schirmbeck, R., Reimann, J., and Autenrieth, I.B. (1999). DNA immunization confers systemic, but not mucosal, protection against enteroinvasive bacteria. Eur. J. Immunol. 29, 986-996.
58. Okada, E., Sasaki, S., Ishii, N., Aoki, I., Yasuda, T., Nishioka, K., Fukushima, J., Miyazaki, J., Wahren, B., and Okuda, K. (1997). Intranasal immunization of a DNA vaccine with IL-12- and GMCSF-expressing plasmids in liposomes induces strong mucosal and cell-mediated immune responses against HIV-1 antigens. J. Immunol. 159, 3638-3647.
59. Paganelli, R., Scala, E., Quinti, I., and Ansotegui, I.J. (1994). Humoral immunity in aging. Aging (Milano) 6, 143-150.
60. Razin, A., and Friedman, J. (1981). DNA methylation and its possible biological roles. Prog. Nucleic Acid Res. Mol. Biol. 25, 33-52.
61. Roman, M., Martin-Orozco, E., Goodman, J.S., Mguyen, M., Sato, Y., Ronaghy, A., Kornbluth, R.S., Richman, D.D., Carson, D.A., and Raz, E. (1997). Immunostimulatory DNA sequences function as T helper-1 promoting adjuvants. Nat. Med. 3, 849-854.
62. Sato, Y., Roman, M., Tighe, H., Lee, D., Corr, M., Nguyen, M., Carson, D.A., and Raz, E. (1996). Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 273, 352-354.
63. Sedegah, M., Hederstorm, R., Hobert, P., and Hoffman, S.L. (1994). Protection against malaria by immunization with plasmid DNA encoding circumsprozoite protein. Proc. Natl. Acad. Sci. USA 91, 9866-9870.
64. Seelos, C. (1999). Lessons from Iraq on bioweapons. Nature 398, 187-188.
65. Segal, B.M., Klinman, D.M., and Shevach, E.M. (1997). Microbial products induce autoimmune disease by an IL-12 dependent process. J. Immunol. 158, 5087-5091.
66. Sparwasser, T., and Lipford, G.B. (1999). Consequences of bacterial CpG DNA-driven activation of antigen presenting cells. Curr. Top. Microbiol. Immunol., in press.
67. Sparwasser, T., Meithke, T., Lipford, G., Borschert, K., Hicker, H., Heeg, K., and Wagner, H. (1997a). Bacterial DNA causes septic shock. Nature 386, 336-338.
68. Sparwasser, T., Miethke, T., Lipford, G., Erdmann, A., Hacker, H., Heeg, K., and Wagner, H. (1997b). Macrophages sense pathogens via DNA motifs: Induction of tumor necrosis factor-a-mediated shock. Eur. J. Immunol. 27, 1671-1679.
69. Sparwasser, T., Koch, E.S., Vabulas, R.M., Heeg, K., Lipford, G.B., Ellwart, J.W., and Wager, H. (1998). Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells. Eur. J. Immunol. 28, 2045-2054.
70. Stacey, K.J., Sweet, M.J., and Hume, D.A. (1996). Macrophages ingest and are activated by bacterial DNA. J. Immunol. 157, 2116-2120.
71. Stein, C.A., and Cheng, Y.C. (1993). Antisense oligonucleotides as therapeutic agents - is the bullet really magical? Science 261,1004-1012.
72. Steinberg, A.D., Krieg, A.M., Gourley, M.F., and Klinman, D.M. (1990). Theoretical and experimental approaches to generalized autoimmunity. Immunol. Rev. 118, 129-163.
73. Sun, S., Beard, C., Jaenisch, R., Jones, P., and Sprent, J. (1997). Mitogenicity of DNA from different organisms for murine B cells. J. Immunol. 159, 3119-3125.
74. Sun, S., Zhang, X., Tough, D.F., and Sprent, J. (1998). Type I interferon-mediated stimulation of T cells by CpG DNA. J. Exp. Med. 188, 2335-2342.
75. Ulmer, J.B., Donnelly, J.J., Parker, S.E., Rhodes, G.H., Felgner, P.L., Dwarki, V.J., Gromkoski, S.H., Deck, R.R., Dewitt, C.M., and Friedman, A. (1993). Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259, 1745-1749.
76. Ulmer, J.B., Deck, R.R., Dewitt, C.M., Fu, T., Donnelly, J.J., Caulfield, M.J., and Liu, M.A. (1997). Expression of a viral protein by muscle cells in vivo induces protective cell-mediated immunity. Vaccine 8, 839-845.
77. Vanderzanden, L., Bray, M., Fuller, D., Roberts, T., Custer, D., Spik, K., Jahrling, P., Huggins, J., Schmaljohn, A., and Schmaljohn, C. (1998). DNA vaccines expressing either the GP or NP genes of Ebola virus protect mice from lethal challenge. Virology 246, 134-144.
78. Wagner, H. (1999). Bacterial CpG-DNA activates immune cells to signal "infectious danger." Adv. Immunol., in press.
79. Wang, B., Boyer, J.D., Uden, K.E., Srikantan, V., Ayyaroo, V., Agadijanyan, M.G., Williams, W.V., Newman, M., Coney, L., Carano, R., and Weiner, D.B. (1995). Nucleic acid-based immunization against HIV-1: Induction of protective in vivo immune responses. AIDS 9 (suppl A), S159-S170.
80. Wang, R., Doolan, D.L., Le, T.P., Hedstrom, R.C., Coonan, K.M., Charoenvit, Y., and Hoffman, S.L. (1998). Induction of antigen specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. Science 282, 476-480.
81. Weeratna, R., Brazolot Millan, C.L., Krieg, A.M., and Davis, H.L. (1998). Reduction of antigen expression from DNA vaccines by coadministered oligodeoxynucleotides. Antisense Nucleic Acid Drug Dev. 8, 351-356.
82. Weiss, W.R., Ishii, K.J., Hedstrom, R.C., Sedegah, M., Ichino, M., Barnhart, K., Klinman, D.M., and Hoffman, S.L. (1998). A plasmid encoding granulocyte-macrophage colony-stimulating factor increases protection conferred by a malaria DNA vaccine. J. Immunol. 161, 2325-2332.
83. Wolff, J.A., Malone, R.W., Williams, P., Chong, W., Ascadi, G., Jani, A., and Felgner, P.L. (1990). Direct gene transfer into mouse muscle in vivo. Science 247, 1465-1468.
84. Xiang, Z.Q., and Ertl, H.C.J. (1995). Manipulation of immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines. Immunity 2, 129-135.
85. Xiang, Z.Q., Spitalnik, S.L., Cheng, J., Erikson, J., Wojczyk, B., and Ertl, H.C. (1995). Immune responses to nucleic acid vaccines to rabies virus. Virology 209, 569-579.
86. Xu, L., Sanchez, A., Yang, Z., Zaki, S.R., Nabel, E.G., Nichol, S.T., and Nabel, G.J. (1998). Immunization for Ebola virus infection. Nat. Med. 4, 37-42.
87. Yamamoto, S., Yamamoto, T., Katoaka, T., Kuramoto, E., Yano, O., and Tokunaga, T. (1992). Unique palindromic sequences in synthetic oligonucleotides are required to induce IFN and augment IFN-mediated natural killer activity. J. Immunol. 148, 4072-4076.
88. Yi, A.K., and Krieg, A.M. (1998). Rapid induction of mitogen-activated protein kinases by immune stimulatory CpG DNA. J. Immunol. 161, 4493-4497.
89. Yi, A., Klinman, D.M., Martin, T.L., Matson, S., and Krieg, A.M. (1996a). Rapid immune activation by CpG motifs in bacterial DNA. J. Immunol. 157, 5394-5402.
90. Yi, A., Hornbeck, P., Lafrenz, D.E., and Krieg, A.M. (1996b). CpG DNA rescue of murine B lymphoma cells from anti-IgM induced growth arrest and programmed cell death is associated with increased expression of c-myc and bcl-xl. J Immunol. 157, 4918-4925.
91. Yi, A.K., Tuetken, R., Redford, T., Waldschmidt, M., Kirsch, J., and Krieg, A.M. (1998). CpG motifs in bacterial DNA activate leukocytes through the pH-dependent generation of reactive oxygen species. J. Immunol. 160, 4755-4761.
92. Zimmermann, S., Egeter, O., Hausmann, S., Lipford, G.B., Rocken, M., Wagner, H., and Heeg, K. (1998). CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine Leishmaniasis. J. Immunol. 160, 3627-3630.